Congenital Heart Disease in ChildrenHOBSNCT04315610
Personalized Mobile App for Parents of Infants With Cardiac Disease
A study testing Access to mobile phone application and Treatment as usual in people with Congenital Heart Disease in Children and Stress, Psychological, run by Oslo University Hospital at 1 site in Norway.
Trial summary
This project implements an eHealth intervention targeted at vulnerable infants with cardiac disease and specifically study how this intervention impact their parents coping, stress levels and personal wellbeing. The intervention will be evaluated through a pragmatic controlled trial. Read more about this study
- Who is it for?
- Ages Up to 3 months
- Conditions the study is for
- Congenital Heart Disease in Children, Stress, Psychological
- What is being tested?
- Access to mobile phone application and Treatment as usual
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 154 participants
- Where
- 1 siteNorway
- Study dates
- 1 Jun 2021to 30 Sep 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Up to 3 months
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Infants below 3 months age diagnosed with severe heart disease at NICD at OUH
Who cannot join
- Gestational age below 34 weeks b) Isolated arrhythmic disorders c) Language barriers d) Need of advanced home care with professional assistance
Trial locations and contacts
1 site in 1 country.
About this study
This project implements an eHealth intervention targeted at vulnerable infants with cardiac disease and specifically study how this intervention impact their parents coping, stress levels and personal wellbeing. The intervention will be evaluated through a pragmatic controlled trial.
The aim of this project is therefore to measure if the features of this mobile application are useful for parents' assessment of deterioration, decision-making and communication with health care providers.
Read the detailed description
This project is a service innovation project where the overall aim is to stimulate service innovation that ensures patient safety to vulnerable infants with severe cardiac disease. We plan to implement and evaluate an eHealth intervention, called HOBS (the Heart OBServation-app), that systemizes and personalizes information and teaching from nurses and other health personnel in order to support parents as caregivers after discharge from hospital. The service innovation will be studied in two consecutive studies; 1) a feasibility study to examine health personnel and parents in-depth perception of relevance, benefit and user friendliness of the application and its features, and 2) a controlled trial to measure the applications impact on parents stress, anxiety, coping and health literacy after discharge, including reasons and outcomes of contact with health services. In addition, we evaluate if nurses' quality of discharge teaching is affected by the application.
In Norway, 500-600 children are born with congenital heart defects (CHD) every year. About 25% of these children present severe problems and symptoms in need of early treatment (1), and 15 % of them die during the first year of life (2). Parents of infants with cardiac disease assume significant, comprehensive caregiving responsibilities, and have shown higher levels of anxiety, depression, and stress. Many parents find it difficult to recognize the symptoms if their child's health and wellbeing deteriorates(3).
New, mobile technology applications and services come with novel opportunities to support these parents with personalized, contextual information at the point of need. For example, interactive functions and presentation of selected information can enable personalized decision-making and communication support. This can improve relevance and quality of discharge teaching from nurses at Neonatal Intensive Care Department (NICD) at Oslo University Hospital (OUH), but more importantly also support local services where CHD seldom occur and knowledge may be sparse. To date, the value added, appropriateness and importance of such opportunities for mental stress and health competence among parents of children with CHD has not been systematically reported. Moreover, if our study goals are achieved, the intervention can empower parents to recognize the early signs before deterioration in their infant manifests, prevent acute episodes at home after discharge, and improve rehabilitation. For the parents this service innovation may reduce psychological strain during a challenging period of life.
Method and data collection A controlled trial with consecutive groups has been chosen to avoid contamination of health personnel's way of guiding and parents interaction at common rooms at the NICD. Even though the access to or use of the application are controlled by the project using a login code we accept that guidance will be affected and more systematic during the implementation of the application and this may affect the results. Hence, a two months break between the last family receiving app in the quality study at OUH and inclusion of the control group is planned. Inclusion of the control group will then be conducted before inclusion of the app group. The control group receives written information in a binder while the intervention group will receive the information through links in the mobile application. A guideline including a checklist of topics to support parents before discharge is similar to both groups.
The intervention HOBS-app is developed by a project group at OUH together with parents and local health personnel for parents with infants with cardiac disease. It is presented in detail at the web-page www.hobs.no. Congenital heart disease is a complicated and individual diagnosis with varied consequences (15). Therefore, at first login, the diagnosis and treatments are registered. Then an algorithm in the application provides parents with a personalized set of observations and a list of adapted information to their infant's needs. Under the guidance of nurses at the NICD at OUH, parents are trained using the app to assess their infant's condition, regarding circulation, breathing, eating habits, well-being, wound healing and more. These observations are stored in the application. In this way parents become better aware of their infant's condition and may help parents to detect signs of deterioration at home. Contact information to local health services is stored before discharge. After discharge, assessments using the application are performed before consultations to health services or if parents are uncertain about deterioration in their infant. After assessments the applications' function for communication support can guide parents in describing a possible deterioration and communication with health personnel may be facilitated.
To reach health professionals with information about HOBS a website will be established with guidance and tips on using the app. An e-learning course is developed and will be distributed nationally through similar educative portals. A link to the website and the e-learning courses are added to the discharge summary that follows the infant to a local hospital.
The purpose of the controlled trial is to answer research question 3: In what ways do the application's content and functionality influence the parents' coping with stress, anxiety, distress of caring for a sick child and health literacy and contact with health services?
- Being tested
- Access to mobile phone application, Treatment as usual
- Medical subject headings
- Stress, Psychological
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Access to mobile phone applicationOther
Under the guidance of healthcare personnel at the Neonatal Intensive Care Department (NICD) at Oslo University Hospital (OUH), parents are trained to assess their infant's condition, regarding circulation, breathing, eating habits, well-being, and more. In addition, before discharge, a baseline assessment of the infant's condition is stored in the application. After discharge, assessments using the application are performed if necessary.
Treatment as usualOther
Active comparator group, based on traditional information and follow-up.
| Study group | Role | What they receive |
|---|---|---|
| Access to mobile application | Experimental | This application will help parents to recognize symptoms of reduced health status in their infant, provide decision-making support, increase their communication skills with health professionals, and provide easier access to quality assured information. At first login, the diagnosis, treatment, and contacts in the health service are registered to provide parents with personalized information that is adapted to their infant's needs. Under the guidance of healthcare personnel at the Neonatal Intensive Care Department (NICD) at Oslo University Hospital (OUH), parents are trained to assess their infant's condition, regarding circulation, breathing, eating habits, well-being, and more. In addition, before discharge, a baseline assessment of the infant's condition is stored in the application. Receives: Other: Access to mobile phone application |
| Treatment as usual | Active comparator | This group receives traditional oral and written information about their child's heart defect and further follow-up. Receives: Other: Treatment as usual |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pediatric Inventory for Parents (PIP)
The PIP measures parental stress related to children with chronic disease and is the primary endpoint regarding psychological adaption. It contains 42 items that are answered on a 5-point Likert scale within four domains: 1) communication, 2) emotional distance, 3) medical care and 4) role function. All items are answered twice, one for frequency and one for difficulty. Higher score reflects more disease-related stress. The instrument has shown good reliability and content validity. The instrument can provide answers about the causes and degree of stress and anxiety. The instrument has been translated into Norwegian using acknowledged methods.
Measured: Baseline, 1 and 4 months
Secondary outcomes (6)
Health literacy Questionnaire (HLQ)
The HLQ is a multidimensional instrument that measures health competence and has good validity and reliability. It consists of nine areas within health competence, and a selection can be made based on the intervention's objective (42). The following four scales will be used in this study (number from original questionnaire in parentheses): (6) ability to interact with health professionals, (7) orientation in health care, (8) ability to find good health information, and (9) understanding health information in order to know what action to take. In total, 20 items will be answered. The instrument is translated into Norwegian and has been subject to psychometric assessment in an adult population. Scores range between 1 to 4 (for first 5 scales) and 1 to 5 (for scales 6 to 9), and higher value indicates better literacy.
Measured: 4 months
Post Discharge Coping Difficulty Scale (PDCDS)
PDCDS measures parental coping after discharge and is the primary outcome after 1 month. It has good reliability and validity. The instrument is translated in to Norwegian and has acceptable reliability (0.71) (18) . The scale uses an 11 point format with anchor words ("not at all" to "totally") at the 0 and 10 poles of the scale, where higher value indicates more difficulties. Five of the questions have an additional open ended question that elaborates what kind of difficulties parents' experience.
Measured: 1 month
Edinburgh postnatal depression scale (EPDS)
The EPDS is a self-rating scale developed to screen for postnatal depression. It consists of 10 items. Each statement has four possible responses, which are scored from 0 to 3, depending on the severity of the response. Higher scores indicate more severe depressive symptoms with a maximum total score of 30. It has been translated into Norwegian with good reliability: Cronbach's alpha of 0.89. Depression is a common challenge among parents of infants with CHD, and it may affect other dependent outcomes like PIP and perception of coping and knowledge in the study.
Measured: Baseline, 1 and 4 months
Quality of discharge teaching scale (QDTS)
The QDTS consists of 18 items using a similar format as the RHDS, with two subscales and questions about the information given by nurses. It has good reliability and validity (34). The instrument is translated into Norwegian and has demonstrated good reliability, with Cronbach's alpha of 0.89. The content subscale consists of six paired items where parents assess needed and received information regarding preparation for discharge. The second subscale consists of 12 items and reflects nurses' skills as educators. This instrument detected significantly increased content of information in parents of infants with CHD receiving written information compared to standard oral information in 2013.
Measured: At discharge from local hospital (up to 5 days)
Readiness for hospital discharge (RHDS)
The RHDS is based on transition theory. It measures parents' perception of readiness for hospital discharge and is the primary outcome at discharge. It consists of 23 items and has good validity and reliability. It has been translated into Norwegian. It contains four subscales regarding discharge preparedness: 1) parent and child personal status, 2) knowledge, 3) coping ability and 4) expected support. The scale uses an 11-point format with anchor words ("not at all" and "totally") at the 0 and 10 poles of the scale. Our hypothesis is that higher availability of information and more systematic observations of the infant's appearance will increase perception of readiness and knowledge compared to standard care.
Measured: At discharge from local hospital (up to 5 days)
User log and additional questions
To observe parents' use of HOBS, log data about use will be extracted. This includes settings at discharge, time and frequency of assessments of the infant and use of information links. The log data can illuminate user patterns, which features are most used and how use of HOBS changes over time.
Measured: From inclusion until 4 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Mar 2020
- Study start1 Jun 2021
- Primary completion30 Sep 2023
- Study completion30 Sep 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Congenital Heart Disease in ChildrenStudies of the same condition, open and under way.
- More trials run by Oslo University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Non-randomised
- Intervention model
- Sequential
- Masking
- None (open label)
- Enrolment
- 154 participants (actual)
Sponsor and investigators
- Lead sponsor
- Oslo University Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- Norwegian Association for Children with Congenital Heart Disease (FFHB)
- Responsible party
- Principal investigator, Henrik Holmstrøm, Oslo University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04315610
- Sponsor's protocol ID
- 19/23041
- Acronym
- HOBS
- Status last verified
- Feb 2025
- First submitted
- 16 Oct 2019
- Last updated
- 4 Mar 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Hjorth-Johansen E, Borosund E, Martinsen Osten I, Holmstrom H, Moen A. Acceptability and Initial Adoption of the Heart Observation App for Infants With Congenital Heart Disease: Qualitative Study. JMIR Form Res. 2023 Apr 5;7:e45920. doi: 10.2196/45920.
PubMed 37018028Hjorth-Johansen E, Borosund E, Moen A, Harmens A, Martinsen I, Wik G, Fredriksen BE, Eger SHW, Holmstrom H. Heart OBServation app: development of a decision support tool for parents of infants with severe cardiac disease. Cardiol Young. 2023 Aug;33(8):1350-1358. doi: 10.1017/S1047951122002438. Epub 2022 Aug 8.
PubMed 35938297Hjorth-Johansen E, Borosund E, Moen A, Osten IM, Wik G, Solevag AL, Eger SHW, Holmstrom H. An individualised mobile app was beneficial for the mothers of infants with severe congenital heart defects. Acta Paediatr. 2025 Jun;114(6):1238-1248. doi: 10.1111/apa.17556. Epub 2024 Dec 21.
PubMed 39707745
Study at a glance
From the registry record, last updated by the sponsor on 4 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Personalized Mobile App for Parents of Infants With Cardiac Disease
- ClinicalTrials.gov ID
- NCT04315610
- Acronym / sponsor ID
- HOBS / 19/23041
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 154 participants (actual)
- Lead sponsor
- Oslo University HospitalUniversity, hospital or other
- Collaborators
- Norwegian Association for Children with Congenital Heart Disease (FFHB)
- Study start
- 1 Jun 2021 (actual)
- Primary completion
- 30 Sep 2023 (actual)
- Study completion
- 30 Sep 2023 (actual)
- First posted
- 19 Mar 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This project implements an eHealth intervention targeted at vulnerable infants with cardiac disease and specifically study how this intervention impact their parents coping, stress levels and personal wellbeing. The intervention will be evaluated through a pragmatic controlled trial.
The aim of this project is therefore to measure if the features of this mobile application are useful for parents' assessment of deterioration, decision-making and communication with health care providers.
Detailed description
This project is a service innovation project where the overall aim is to stimulate service innovation that ensures patient safety to vulnerable infants with severe cardiac disease. We plan to implement and evaluate an eHealth intervention, called HOBS (the Heart OBServation-app), that systemizes and personalizes information and teaching from nurses and other health personnel in order to support parents as caregivers after discharge from hospital. The service innovation will be studied in two consecutive studies; 1) a feasibility study to examine health personnel and parents in-depth perception of relevance, benefit and user friendliness of the application and its features, and 2) a controlled trial to measure the applications impact on parents stress, anxiety, coping and health literacy after discharge, including reasons and outcomes of contact with health services. In addition, we evaluate if nurses' quality of discharge teaching is affected by the application.
In Norway, 500-600 children are born with congenital heart defects (CHD) every year. About 25% of these children present severe problems and symptoms in need of early treatment (1), and 15 % of them die during the first year of life (2). Parents of infants with cardiac disease assume significant, comprehensive caregiving responsibilities, and have shown higher levels of anxiety, depression, and stress. Many parents find it difficult to recognize the symptoms if their child's health and wellbeing deteriorates(3).
New, mobile technology applications and services come with novel opportunities to support these parents with personalized, contextual information at the point of need. For example, interactive functions and presentation of selected information can enable personalized decision-making and communication support. This can improve relevance and quality of discharge teaching from nurses at Neonatal Intensive Care Department (NICD) at Oslo University Hospital (OUH), but more importantly also support local services where CHD seldom occur and knowledge may be sparse. To date, the value added, appropriateness and importance of such opportunities for mental stress and health competence among parents of children with CHD has not been systematically reported. Moreover, if our study goals are achieved, the intervention can empower parents to recognize the early signs before deterioration in their infant manifests, prevent acute episodes at home after discharge, and improve rehabilitation. For the parents this service innovation may reduce psychological strain during a challenging period of life.
Method and data collection A controlled trial with consecutive groups has been chosen to avoid contamination of health personnel's way of guiding and parents interaction at common rooms at the NICD. Even though the access to or use of the application are controlled by the project using a login code we accept that guidance will be affected and more systematic during the implementation of the application and this may affect the results. Hence, a two months break between the last family receiving app in the quality study at OUH and inclusion of the control group is planned. Inclusion of the control group will then be conducted before inclusion of the app group. The control group receives written information in a binder while the intervention group will receive the information through links in the mobile application. A guideline including a checklist of topics to support parents before discharge is similar to both groups.
The intervention HOBS-app is developed by a project group at OUH together with parents and local health personnel for parents with infants with cardiac disease. It is presented in detail at the web-page www.hobs.no. Congenital heart disease is a complicated and individual diagnosis with varied consequences (15). Therefore, at first login, the diagnosis and treatments are registered. Then an algorithm in the application provides parents with a personalized set of observations and a list of adapted information to their infant's needs. Under the guidance of nurses at the NICD at OUH, parents are trained using the app to assess their infant's condition, regarding circulation, breathing, eating habits, well-being, wound healing and more. These observations are stored in the application. In this way parents become better aware of their infant's condition and may help parents to detect signs of deterioration at home. Contact information to local health services is stored before discharge. After discharge, assessments using the application are performed before consultations to health services or if parents are uncertain about deterioration in their infant. After assessments the applications' function for communication support can guide parents in describing a possible deterioration and communication with health personnel may be facilitated.
To reach health professionals with information about HOBS a website will be established with guidance and tips on using the app. An e-learning course is developed and will be distributed nationally through similar educative portals. A link to the website and the e-learning courses are added to the discharge summary that follows the infant to a local hospital.
The purpose of the controlled trial is to answer research question 3: In what ways do the application's content and functionality influence the parents' coping with stress, anxiety, distress of caring for a sick child and health literacy and contact with health services?
Study design
- Primary purpose
- Supportive care
- Allocation
- Non-randomised
- Intervention model
- Sequential
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Access to mobile application | Experimental | Other: Access to mobile phone applicationThis application will help parents to recognize symptoms of reduced health status in their infant, provide decision-making support, increase their communication skills with health professionals, and provide easier access to quality assured information. At first login, the diagnosis, treatment, and contacts in the health service are registered to provide parents with personalized information that is adapted to their infant's needs. Under the guidance of healthcare personnel at the Neonatal Intensive Care Department (NICD) at Oslo University Hospital (OUH), parents are trained to assess their infant's condition, regarding circulation, breathing, eating habits, well-being, and more. In addition, before discharge, a baseline assessment of the infant's condition is stored in the application. |
| Treatment as usual | Active comparator | Other: Treatment as usualThis group receives traditional oral and written information about their child's heart defect and further follow-up. |
Who may qualify
- Ages
- Up to 3 months
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (1 listed)
- Infants below 3 months age diagnosed with severe heart disease at NICD at OUH
Key exclusion criteria (1 listed)
- Gestational age below 34 weeks b) Isolated arrhythmic disorders c) Language barriers d) Need of advanced home care with professional assistance
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Access to mobile phone applicationUnder the guidance of healthcare personnel at the Neonatal Intensive Care Department (NICD) at Oslo University Hospital (OUH), parents are trained to assess their infant's condition, regarding circulation, breathing, eating habits, well-being, and more. In addition, before discharge, a baseline assessment of the infant's condition is stored in the application. After discharge, assessments using the application are performed if necessary. | Other | Access to mobile application |
| Treatment as usualActive comparator group, based on traditional information and follow-up. | Other | Treatment as usual |
Primary outcome
Pediatric Inventory for Parents (PIP)
Time frame: Baseline, 1 and 4 months
The PIP measures parental stress related to children with chronic disease and is the primary endpoint regarding psychological adaption. It contains 42 items that are answered on a 5-point Likert scale within four domains: 1) communication, 2) emotional distance, 3) medical care and 4) role function. All items are answered twice, one for frequency and one for difficulty. Higher score reflects more disease-related stress. The instrument has shown good reliability and content validity. The instrument can provide answers about the causes and degree of stress and anxiety. The instrument has been translated into Norwegian using acknowledged methods.
6 secondary outcomes
Health literacy Questionnaire (HLQ)
Time frame: 4 months
Post Discharge Coping Difficulty Scale (PDCDS)
Time frame: 1 month
Edinburgh postnatal depression scale (EPDS)
Time frame: Baseline, 1 and 4 months
Quality of discharge teaching scale (QDTS)
Time frame: At discharge from local hospital (up to 5 days)
Readiness for hospital discharge (RHDS)
Time frame: At discharge from local hospital (up to 5 days)
User log and additional questions
Time frame: From inclusion until 4 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Mar 2025.
- Background: PubMed 37018028Hjorth-Johansen E, Borosund E, Martinsen Osten I, Holmstrom H, Moen A. Acceptability and Initial Adoption of the Heart Observation App for Infants With Congenital Heart Disease: Qualitative Study. JMIR Form Res. 2023 Apr 5;7:e45920. doi: 10.2196/45920.
- Background: PubMed 35938297Hjorth-Johansen E, Borosund E, Moen A, Harmens A, Martinsen I, Wik G, Fredriksen BE, Eger SHW, Holmstrom H. Heart OBServation app: development of a decision support tool for parents of infants with severe cardiac disease. Cardiol Young. 2023 Aug;33(8):1350-1358. doi: 10.1017/S1047951122002438. Epub 2022 Aug 8.
- Results publication: PubMed 39707745Hjorth-Johansen E, Borosund E, Moen A, Osten IM, Wik G, Solevag AL, Eger SHW, Holmstrom H. An individualised mobile app was beneficial for the mothers of infants with severe congenital heart defects. Acta Paediatr. 2025 Jun;114(6):1238-1248. doi: 10.1111/apa.17556. Epub 2024 Dec 21.
- Individual participant dataSharing planned: No
Related trials for Congenital Heart Disease in Children
RecruitingPhase 1/2
Influence of Personalized Lung Volume Optimization Maneuver on Lung Function and Cardiac Performance in Children
Congenital Heart Disease, Cardiopulmonary Bypass
Not yet recruitingPhase 1/2
Influence of Lung Volume Optimization Maneuver on Cardiac Output and Lung Compliance in Ventilated Children With Congenital Heart Disease Undergoing Surgical Repair
Congenital Heart Disease, Cardiopulmonary Bypass
RecruitingPhase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
Congenital Heart Disease in Children
Not yet recruiting
AI-Guided Mechanical Ventilation in Children: A Randomized Controlled Trial
Acute Respiratory Distress Syndrome, Pneumonia in Children
Recruiting
Screening for Disorders of Lipid Metabolism and Familial Hyperlipidemia in Children and Adolescents With Increased Cardiovascular Risk Due to Chronic Diseases Such as Congenital Heart Disease, Chronic Inflammatory Bowel Disease, Celiac Disease and Rheumatic Disorders
Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Access to mobile phone application and Treatment as usual in people with Congenital Heart Disease in Children and Stress, Psychological, run by Oslo University Hospital at 1 site in Norway.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pediatric Inventory for Parents (PIP) (time frame: Baseline, 1 and 4 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04315610, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Mar 2025; AzTrials last refreshed its copy on 8 Nov 2026.